Wells Fargo
UTMD icon

Wells Fargo’s Utah Medical Products UTMD Stock Holding History

Wells Fargo’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.9K Sell
1,144
-2,981
-72% -$188K ﹤0.01% 5294
2025
Q4 		$231K Buy
4,125
+1,779
+76% +$103K ﹤0.01% 4989
2025
Q3 		$148K Buy
2,346
+361
+18% +$21.4K ﹤0.01% 5100
2025
Q2 		$113K Buy
1,985
+95
+5% +$5.17K ﹤0.01% 5122
2025
Q1 		$106K Sell
1,890
-37
-2% -$2.22K ﹤0.01% 5076
2024
Q4 		$118K Buy
1,927
+384
+25% +$24.8K ﹤0.01% 5106
2024
Q3 		$103K Buy
1,543
+31
+2% +$2.1K ﹤0.01% 5005
2024
Q2 		$101K Buy
1,512
+300
+25% +$20.4K ﹤0.01% 4937
2024
Q1 		$86.2K Buy
1,212
+139
+13% +$10.4K ﹤0.01% 4973
2023
Q4 		$90.4K Buy
1,073
+202
+23% +$16.8K ﹤0.01% 4971
2023
Q3 		$74.9K Sell
871
-728
-46% -$67.2K ﹤0.01% 4951
2023
Q2 		$149K Buy
1,599
+763
+91% +$71.9K ﹤0.01% 4773
2023
Q1 		$79.3K Buy
836
+661
+378% +$60.8K ﹤0.01% 4927
2022
Q4 		$17.6K Sell
175
-58
-25% -$5.29K ﹤0.01% 5320
2022
Q3 		$20K Sell
233
-34
-13% -$3K ﹤0.01% 5407
2022
Q2 		$23K Sell
267
-4,870
-95% -$415K ﹤0.01% 5386
2022
Q1 		$461K Sell
5,137
-6,204
-55% -$570K ﹤0.01% 4463
2021
Q4 		$1.14M Sell
11,341
-499
-4% -$50.9K ﹤0.01% 4016
2021
Q3 		$1.1M Buy
11,840
+6,250
+112% +$552K ﹤0.01% 4166
2021
Q2 		$476K Sell
5,590
-8,056
-59% -$697K ﹤0.01% 4647
2021
Q1 		$1.18M Buy
13,646
+3,381
+33% +$297K ﹤0.01% 4129
2020
Q4 		$865K Sell
10,265
-914
-8% -$77.9K ﹤0.01% 4139
2020
Q3 		$893K Buy
11,179
+1,635
+17% +$136K ﹤0.01% 3949
2020
Q2 		$845K Buy
9,544
+116
+1% +$10.4K ﹤0.01% 3946
2020
Q1 		$886K Buy
9,428
+2,705
+40% +$251K ﹤0.01% 3620
2019
Q4 		$725K Sell
6,723
-77
-1% -$7.8K ﹤0.01% 4085
2019
Q3 		$652K Buy
6,800
+525
+8% +$48.8K ﹤0.01% 4186
2019
Q2 		$600K Sell
6,275
-12,718
-67% -$1.07M ﹤0.01% 4258
2019
Q1 		$1.68M Sell
18,993
-3,302
-15% -$290K ﹤0.01% 3501
2018
Q4 		$1.85M Buy
22,295
+1,006
+5% +$88.6K ﹤0.01% 3336
2018
Q3 		$2M Sell
21,289
-820
-4% -$78.3K ﹤0.01% 3406
2018
Q2 		$2.44M Sell
22,109
-177
-0.8% -$18.5K ﹤0.01% 3303
2018
Q1 		$2.2M Sell
22,286
-6,178
-22% -$551K ﹤0.01% 3301
2017
Q4 		$2.32M Buy
28,464
+1,210
+4% +$94.5K ﹤0.01% 3258
2017
Q3 		$2M Buy
27,254
+6,821
+33% +$491K ﹤0.01% 3312
2017
Q2 		$1.48M Sell
20,433
-200
-1% -$13.2K ﹤0.01% 3433
2017
Q1 		$1.28M Buy
20,633
+1
+0% +$63 ﹤0.01% 3556
2016
Q4 		$1.5M Buy
20,632
+18,408
+828% +$1.2M ﹤0.01% 3387
2016
Q3 		$133K Sell
2,224
-196
-8% -$12.5K ﹤0.01% 4732
2016
Q2 		$152K Sell
2,420
-363
-13% -$23.4K ﹤0.01% 4565
2016
Q1 		$174K Buy
2,783
+294
+12% +$17.3K ﹤0.01% 4488
2015
Q4 		$146K Buy
2,489
+1,474
+145% +$83.6K ﹤0.01% 4660
2015
Q3 		$54K Sell
1,015
-173
-15% -$9.44K ﹤0.01% 5239
2015
Q2 		$71K Buy
1,188
+391
+49% +$22K ﹤0.01% 5205
2015
Q1 		$48K Buy
797
+23
+3% +$1.35K ﹤0.01% 5029
2014
Q4 		$46K Buy
774
+1
+0.1% +$55 ﹤0.01% 5035
2014
Q3 		$37K Sell
773
-95
-11% -$4.83K ﹤0.01% 5048
2014
Q2 		$45K Sell
868
-1,032
-54% -$53K ﹤0.01% 5014
2014
Q1 		$110K Sell
1,900
-400
-17% -$21.8K ﹤0.01% 4616
2013
Q4 		$131K Sell
2,300
-1,200
-34% -$65.8K ﹤0.01% 4431
2013
Q3 		$208K Hold
3,500
– – ﹤0.01% 4188
2013
Q2 		$190K Buy
+3,500
New +$165K ﹤0.01% 4153

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo's UTMD Position: Q1 2026 in Review

Wells Fargo reduced its Utah Medical Products (UTMD) stake by 72% in Q1 2026, selling an estimated $188K and leaving 1,144 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5294.

Wells Fargo first reported a position in UTMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.44M in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Wells Fargo held 1,144 shares of Utah Medical Products worth $70.9K as of Q1 2026.
  • Wells Fargo sold 2,981 Utah Medical Products shares in Q1 2026, an estimated $188K.
  • Utah Medical Products made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5294 holding.
  • Wells Fargo first reported a position in Utah Medical Products in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Utah Medical Products position peaked at $2.44M in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.